News

How a New Weight-Loss Pill Could Transform Health
In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...
CNBC Daily Open: Consumers are worried over the economy. The White House insists it'll be fine
White House officials are preaching the sense of Trump’s economic policy. A Federal Reserve survey is the latest to show ...
Meta faces historic antitrust trial that could force it to break off Instagram, WhatsApp
Meta c Mark Zuckerberg took the stand on Monday in a historic antitrust trial that could force the tech giant to break off ...
Pfizer shelves obesity pill plan after patient suffers liver injury during clinical trial
Pfizer Inc. has said it will discontinue development of its closely watched obesity pill, danuglipron, dealing a severe blow ...
Le Lézard4d
Novo Nordisk warns consumers about counterfeit Ozempic® (semaglutide) injection 1 mg in the US
Novo Nordisk has become aware of several hundred units of Ozempic® (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized supply chain in the US. The US Food and Drug ...
Korea JoongAng Daily on MSN4d
Pfizer ends development of weight-loss pill danuglipron
Pfizer on Monday said it had discontinued the development of the experimental weight-loss pill danuglipron after a trial ...
Politico Europe5d
Trump says pharma tariffs will entice back drug production. They won’t.
And while Trump has criticized Ireland for attracting big pharma companies, he’s also suggested he wants to reshore ...
Newseria BIZNES5d
Recombinant Proteins Market Forecasted to Reach $7.48 Billion by 2034, Growing at 8.00% CAGR
Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...